Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christpher Klifto

Hand Surgery Durham, NC Medical Doctor

NPI 1164713947 CMS profile 4227058

3609 Sw Durham Dr, Durham, NC 27707

Open in the dashboard

General payments

$575,411

658 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$6,765

1 holding reported · through program year 2025

Research they led as principal investigator

$72,787 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Christpher Klifto of Durham, NC is reported in the CMS Open Payments database as having received $575,411 across 658 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $72,787 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $6,765 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $202,439 184
2024 General $147,931 152
2023 General $82,327 108
2022 General $66,431 94
2021 General $28,056 33
2020 General $20,180 26
2019 General $28,047 61
2025 Ownership $6,765 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christpher Klifto
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Christpher Klifto were reported at $202,439. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Christpher Klifto Hand Surgery median Middle half National median
2019 $28,047 $383 $106–$1,905 $163
2020 $20,180 $172 $51–$1,268 $114
2021 $28,056 $263 $71–$1,591 $132
2022 $66,431 $336 $87–$1,938 $149
2023 $82,327 $233 $81–$1,114 $160
2024 $147,931 $258 $88–$1,203 $164
2025 $202,439 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $498,612 503 payments
  2. Integra LifeSciences Corporation $47,332 67 payments
  3. Acumed LLC $13,534 13 payments
  4. Stryker Corporation $7,949 27 payments
  5. SouthTech Orthopedics $2,599 4 payments
  6. Medartis Inc. $1,209 6 payments
  7. Exactech, Inc. $676 5 payments
  8. Ascension Orthopedics, Inc. $500 1 payment
  9. Bioventus LLC $426 5 payments
  10. DePuy Synthes Sales Inc. $415 5 payments
  11. Other $2,160 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $416,399 155 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $79,916 29 payments
  3. Travel and Lodging $56,282 170 payments
  4. Food and Beverage $19,905 299 payments
  5. Education $2,910 5 payments
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $148,708 87 payments
  2. AETOS Shoulder System $113,377 127 payments
  3. TWINFIX $110,700 89 payments
  4. TITAN-SHOULDER $43,110 52 payments
  5. FREEDOM WRIST $42,584 47 payments
  6. EXTERNAL FIXATION SYSTEM $42,584 47 payments
  7. REVERSE SHOULDER $38,141 26 payments
  8. Bioinductive Implant with Arthroscopic Delivery System - Medium $36,816 29 payments
  9. Bone Anchors with Arthroscopic Delivery System $26,977 18 payments
  10. Mini-Open Latarjet $23,572 9 payments
  11. Other $371,458 399 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

159

Median for Orthopedic Surgery: 203

Drug cost

$904

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 11 $251
Meloxicam Generic 57 $186
Methylprednisolone Generic 23 $175
Gabapentin Generic 12 $91
Oxycodone Hcl Generic 20 $86
Ibuprofen Generic 13 $62
Tramadol Hcl Generic 23 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 83 billing codes

Paid by Medicare

$303,281

Of which drugs: $3,005

Medicare patients

620

Average age 73

Services billed

4,494

399 women, 221 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 74%
High blood pressure 71%
Chronic kidney disease 28%
Depression 28%
Diabetes 27%
Ischemic heart disease 24%
Osteoporosis 21%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 113 424 $2,233
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 145 924 $689
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 145 916 $79

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

658 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record